Skip to main content
. 2018 Jun 26;9(3):85–90. doi: 10.14740/wjon1097w

Figure 1.

Figure 1

(a) Overall postoperative cancer-specific survival of patients based on Glasgow prognostic score (GPS, P < 0.001); (b) neutrophil-to-lymphocyte ratio (NLR, P < 0.001); (c) platelet-to-lymphocyte ratio (PLR, P < 0.001); (d) prognostic nutritional index (PNI, P = 0.014); (e) systemic immune-inflammation index (SII, P < 0.001); (f) advance lung cancer inflammation index (ALI, P < 0.001).